highly significantp-value <0.05
Of these AABs, three of them—ANGPT2, SELE, and CAV2—are detected in ARDS+ patients with a highly significant difference ( Figure 4A and Figure S4 ) (Wilcoxon test p-value <0.05) over ARDS− patients.
1
0.0500
0.0500
Of these AABs, three of them—ANGPT2, SELE, and CAV2—are detected in ARDS+ patients with a highly significant difference ( Figure 4A and Figure S4 ) (Wilcoxon test p-value <0.05) over ARDS− patients.